Platelet activationprotects againstbacterial lung injury via the TLR4/MYD88 pathway

Read full text Summarise with VIRAT
Authors: Xiaoling Wang, Lihu Wang, Lirong Wang, Ruihe Shen, Xiaolei Zhu
Cited by: 0
References: 36

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Bacterial infections, particularly those caused by Streptococcus pneumoniae ( S. pneumoniae ), are a leading cause of lung injury and respiratory failure. Although platelets have recently emerged as key modulators of immune responses and inflammation. This study investigated the protective effects and underlying mechanisms of platelets in lung injury using a S. pneumoniae -infected mouse model and a lipopolysaccharide (LPS)-induced A549 cell model. Specifically, LPS was utilized as a tool to activate platelets. In vivo results demonstrated that platelet administration significantly attenuated lung histopathological damage, inhibited immune cell activation, and suppressed the secretion of pro-inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and IL-1β. Furthermore, platelet treatment effectively restored antioxidant balance by reducing malondialdehyde levels and enhancing superoxide dismutase and catalase activities. Mechanistically, LPS triggered platelet activation via the Toll-like receptor 4 (TLR4)/myeloid differentiation primary response 88 (MYD88) signaling pathway. In vitr o experiments further confirmed that activated platelets downregulated the expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and suppressed inflammation and oxidative stress in LPS-induced A549 cells; however, these protective effects were abolished by TLR4 or MYD88 inhibitors. In conclusion, platelets activated by LPS through the TLR4/MYD88 pathway confer protection against bacterial infection-induced lung injury by inhibiting inflammation, oxidative stress, and adhesion molecule expression, highlighting the potential of platelets as therapeutic targets for managing bacterial lung injury.

Fields of Study & Subjects

Immune Response and Inflammation Inflammation biomarkers and pathways Sepsis Diagnosis and Treatment

Publication details

Journal / source
Current Proteomics
Volume
23
Issue
2
Pages
100090–100090
Publication date
25 March 2026
Language
EN